Recurrent nonviral liver disease following liver transplantation.
Recurrent disease after liver transplantation is well recognized and remains a potential cause of premature graft loss. The rates of recurrence are difficult to establish because of the lack of consistency in diagnostic criteria and approaches to diagnosis. Owing to the fact that recurrent parenchymal disease may occur in the presence of normal liver tests, those centers that use protocol biopsies will report greater rates of recurrence. It is important to recognize that rates of recurrence vary according to indication and show little correlation with rates of graft loss from recurrent disease. Recurrance rates are greatest for primary sclerosing cholangitis and autoimmune hepatitis, and low reccurrance rates are reported for alcoholic liver disease and recurrent primary biliary cirrhosis. The impact of recurrent nonalcoholic fatty liver disease is not yet clear. Patients and clinicians need to be aware of the possibility of recurrent disease in the differential diagnosis of abnormal liver tests, and management stategies may require alteration to reduce the impact of disease recurrence on outcome. Finally, an understanding of which diseases do recur after transplantation and identification of the risk factors may lead to a better understanding of the pathogenetic mechanisms of these conditions.
Li
Ka-Kit
KK
Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK.
Neuberger
James
J
D015209:Cholangitis, Sclerosing / Q000150:complications / Q000175:diagnosis / Q000601:surgery; D006084:Graft Rejection / Q000209:etiology; D019693:Hepatitis, Autoimmune / Q000150:complications / Q000175:diagnosis / Q000601:surgery; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000175:diagnosis / Q000601:surgery; D008107:Liver Diseases / Q000150:complications / Q000175:diagnosis* / Q000601:surgery*; D016031:Liver Transplantation; D055502:Secondary Prevention